-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al. -
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart AssociationLY Chen, MK Chung, LA Allen et al.
-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators
-
Percutaneous coronary intervention using a combination of robotics and telecommunications by an operator in a separate physical location from the patient: an early exploration into the feasibility of telestenting (the REMOTE-PCI study)Madder RD, VanOosterhout SM, Jacoby ME et al.
-
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA EditorsAK Gupta, H Jneid, B London et al.
-
Left Ventricular Assist Devices for Lifelong SupportPinney SP, Anyanwu AC, Lala A et al.
-
Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney DiseaseHwang D, Kang J, Yang HM et al.
-
Radionuclide Image-Guided Repair of the HeartA Hess , JT Thackeray , KC Wollert et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
